Major missed opportunity on PHARMAC reform

ACT New Zealand

21 April 2021 - “Pharmaceutical funding was totally absent from today’s health review, and that’s about where it is in this Government’s priorities,” according to ACT Health spokesperson Brooke van Velden.

“The Government will, of course, point to the PHARMAC review announced earlier this year. 

The fact that review explicitly excludes funding considerations and is taking place in cold isolation from health reforms shows how disingenuous this Government’s approach to pharmaceuticals really is.

Read ACT New Zealand press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , New Zealand , Funding